A comprehensive multi-cancer study by researchers at The University of Texas MD Anderson Cancer Center has revealed that ...

Chimeric antigen receptor T cell (CAR-T) therapy is considered one of the landmark achievements of modern medicine. The therapy involves harvesting a patient’s own immune cells, genetically ...

Precision medicine is integral to cancer treatment and commonly relies on sequencing the tumor genome in bulk to identify vulnerabilities (such as gene mutations in cancer cells that can be exploited ...

Breast cancer brain metastasis (BCBM) is a major cause of breast cancer-related mortality, but the molecular mechanisms underlying its progression remain poorly understood. Here, we profiled the tumor ...

Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers ...

HOUSTON, JUNE 16, 2026 ― A comprehensive multi-cancer study from researchers at The University of Texas MD Anderson Cancer Center has revealed that ...

AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.

Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder ...

Spatial analyses uncovered how different tumor regions interact with immune cells and respond to therapies, offering a new ...

In just a few decades, DNA sequencing technologies evolved from slow, manual processes to rapid, automated ones, making ...